Filing metadata

Accession number
0001415889-25-014263
Form type
Form 4
Filer
Theravance Biopharma, Inc.
CIK
CIK 1583107
Filed
May 22, 2025
Reporting period
May 20, 2025
Description
Insider transaction

Explore SEC Filings Hub